Pharma
Lipid-based excipients and active pharmaceutical ingredients „Made in Germany“ – you can rely on us.
Decades of experience and expertise shape today`s quality of our specialties and drive new product developments and operational excellence.
As a result, our brand names are considered all over the globe as the benchmark in parenteral nutrition as well as topical, oral, rectal applications and animal health.
Quality, compliance, functionality and technical support are the cornerstones of the day-to-day cooperation with customers and partners.
Our dedication and strict commitment to highest product purity and safety are reflected every day in the effort of our employees and the pursuit of continuous improvement.
The repeated confirmation of our Good Manufacturing Practices (GMP) by the responsible competent German authority and the US-FDA acknowledge our intention to deliver quality leadership to the healthcare industry.
Brands with tradition
EXCELLENCE IN EXCIPIENTS AND APIs
DYNASAN® Purified monoacid triglycerides
IMWITOR® Highly functionalized lipids for drug delivery systems
MIGLYOL® Reference-quality C8 – C10 esters for pharma formulations
SOFTIGEN® Compendial liquid solubilizer
SOFTISAN® Specialties for topical and oral applications
WITEPSOL® Benchmark hard fats for suppositories and ovules
Lipid-based excipients made in Germany, manufactured in our EU GMP-certified and US FDA-approved production facility
Downloads
Lipids for Solid Dosage Forms
Download PDF
Excipients
Download PDF
Product List
Download PDF
WITEPSOL®
Download PDF
Quality & Regulatory
Download PDF
Excipients for Veterinary Application
Download PDF
Lipid Solutions for Injectables
Download PDF
Engineered Lipid Excellence for Topical Applications
Download PDF
Please consider the environment before printing documents.
From our blog
Acid value as a central, objective quality factor for lipid excipients
The selection and qualification of a manufacturer of excipients and active ingredients is one of the main tasks of quality management, which aims, among other things, to ensure the manufacture of effective and safe pharmaceuticals. In this context, monographs serve as a guide to evaluate raw materials regarding their physico-chemical properties and also help to compare different sources of the "supposedly" same raw material.
Committed to Sustainability – CPHI 2022
In November, the CPHI 2022 in Frankfurt, the leading trade fair for the pharmaceutical industry, finally ended our long absence from trade fairs. We were all very excited to finally see our customers, business partners and friends again, resume personal discussions and make new contacts. One topic was especially important to us: Sustainability. And we were particularly proud of an innovation with a great deal of potential.
“Everything new” at the CPHI 2022 in Frankfurt
Finally, the time has come! We will be live at the CPHI Worldwide with a booth. We had to wait until today to present our new trade fair appearance to you and are all the more pleased to welcome you from November 1st to 3rd, 2022 in Frankfurt. Because nothing can replace face-to-face contact.
Water-free formulations for Topical Applications
Topical uses of our specialty products are a pivotal component of our daily aspiration at IOI Oleo GmbH. The business units Pharma and Personal care have common history and share products and expertise to help customers developing high quality, sensorially appealing formulations.
Drug carriers à la carte from IOI – Precise individuality with WITEPSOL®
According to a conservative estimate, approximately 1,000,000,000 (1 billion) individual patient doses are manufactured annually with our WITEPSOL® products for the application area of pain and fever management. This not only makes us proud, but also underlines our position as a global benchmark.
DYNASAN® 118 – Your Formulation Challenges – Our Solutions
In 1843 the Englishman William Brockedon (1787 - 1854) applied for a patent for the tablet and caused “one of the most tremendous upheavals that the pharmacists have ever experienced”. Thereby active ingredients can be precisely dosed and are very stable, the taking is convenient, the production cheap and they are easy to transport. As a result, tablets occupy a special position today with a share of almost 50% among the drug forms.
Promising Trends from the US Market – IOI Oleo already has the answers
A trend that we are seeing in the market in the USA is the improvement of patient compliance. "Take 1 tablet instead of having to think about regularly taking 3 tablets a day." A trend that we are seeing in the USA addresses just this topic. The goal is to ensure the release of the active ingredients over a longer period after administration. This enables longer intervals between doses and, as a result, improved quality of personal life and an increased chance of successful treatment.
SOFTISAN® 649 – THE plant-based synthetic Lanolin Alternative
Lanolin or wool wax is a versatile ingredient and was used medicinally in ancient times. Lanolin is the secretion from sebum glands of sheep and is formed on the surface of their skin. However, the animals have to be treated with pesticides to protect them from parasites. The problem here is that these pesticides accumulate in the wool wax and can later lead to strong allergic reactions in users. This motivated IOI Oleo GmbH to develop a plant-based, synthetic alternative: et voila, SOFTISAN® 649 has since enriched our portfolio and has, among other things, made a name for itself as a lanolin substitute in the pharmaceutical industry.
MIGLYOL® as the Worldwide Benchmark for Injectables
An infusion can save lives and is used as a basic therapy in all areas of health care. The therapy, however, is complex and error-prone. Just as the patient relies on the correct diagnosis by the doctor and the proper execution by the specialist staff, so must the doctor and specialist staff rely on the quality of the infusions. With the MIGLYOL® product portfolio, the Pharma business unit of IOI Oleo GmbH offers high-quality carriers for injectables (infusions and injections).